Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|March 20, 2026
Sex differences in vaccine-induced immunity in mice immunized with integrase-defective lentiviral vector delivering the SARS-CoV-2 Spike proteinIole Farina, Alessandra Gallinaro, Martina Borghi, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2021
Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunizationRoberta Bona, Zuleika Michelini, Chiara Mazzei, et al.
Viruses|March 6, 2021
Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer ImmunotherapyValeria Morante, Martina Borghi, Iole Farina, et al.
NPJ Vaccines|May 16, 2020
Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaquesMaria Blasi, Elizabeth C Wescott, Erich J Baker, et al.
Biomolecules|October 26, 2024
T Cell Peptide Prediction, Immune Response, and Host-Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 SubjectsIole Macchia, Valentina La Sorsa, Alessandra Ciervo, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2021
Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 PneumoniaStefania Dispinseri, Vito Lampasona, Massimiliano Secchi, et al.
Frontiers in Immunology|February 21, 2018
Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza AntigensAlessandra Gallinaro, Martina Borghi, Roberta Bona, et al.
Cells|April 30, 2021
Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor ModelsMaria Ciccolella, Sara Andreone, Jacopo Mancini, et al.
Vaccines|April 23, 2025
Simian Immunodeficiency Virus-Based Virus-like Particles Are an Efficient Tool to Induce Persistent Anti-SARS-CoV-2 Spike Neutralizing Antibodies and Specific T Cells in MiceAlessandra Gallinaro, Chiara Falce, Maria Franca Pirillo, et al.
NPJ Vaccines|December 10, 2020
Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 EnvsMaria Blasi, Donatella Negri, Kevin O Saunders, et al.
Pageof 4